USNA icon

Usana Health Sciences

31.78 USD
-0.31
0.97%
At close Feb 21, 4:00 PM EST
After hours
31.78
+0.00
0.00%
1 day
-0.97%
5 days
-1.27%
1 month
-7.56%
3 months
-19.26%
6 months
-20.39%
Year to date
-12.67%
1 year
-35.54%
5 years
-54.90%
10 years
-38.91%
 

About: Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Employees: 1,900

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

2% more funds holding

Funds holding: 146 [Q3] → 149 (+3) [Q4]

0.76% more ownership

Funds ownership: 55.77% [Q3] → 56.54% (+0.76%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 47

4% less capital invested

Capital invested by funds: $403M [Q3] → $387M (-$16.1M) [Q4]

39% less call options, than puts

Call options by funds: $50K | Put options by funds: $82K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$38
20%
upside
Avg. target
$38
20%
upside
High target
$38
20%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
DA Davidson
Linda Bolton Weiser
30% 1-year accuracy
34 / 112 met price target
20%upside
$38
Neutral
Maintained
2 Jan 2025

Financial journalist opinion

Based on 7 articles about USNA published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Positive
Zacks Investment Research
2 days ago
5 Low Price-to-Book Stocks Worthy of Value Investors' Attention
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, KT, GBX, USNA and ENS are some such stocks.
5 Low Price-to-Book Stocks Worthy of Value Investors' Attention
Positive
Zacks Investment Research
1 week ago
USNA or STVN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
USNA or STVN: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
2 weeks ago
5 Promising Price-to-Book Value Stocks to Buy in February
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, GBX, KT and ENS are some such stocks.
5 Promising Price-to-Book Value Stocks to Buy in February
Neutral
PRNewsWire
2 weeks ago
Kevin Guest Encourages Confidence, Personal Growth for International Boost Self-Esteem Month
SALT LAKE CITY , Feb. 3, 2025 /PRNewswire/ -- Throughout February, Kevin Guest invites individuals everywhere to celebrate International Boost Self-Esteem Month—a time dedicated to building confidence, fostering self-worth and inspiring personal empowerment. Because self-esteem is the cornerstone of a healthy, fulfilling life—shaping relationships, fueling careers and influencing overall well-being—now is the ideal time for individuals to prioritize themselves and take meaningful steps toward becoming more confident and empowered.
Kevin Guest Encourages Confidence, Personal Growth for International Boost Self-Esteem Month
Neutral
Zacks Investment Research
3 weeks ago
USNA vs. STVN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
USNA vs. STVN: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
3 weeks ago
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Neutral
PRNewsWire
1 month ago
USANA Appoints New Chief Scientific Officer
Dr. Kathryn Armstrong brings 17 years of scientific expertise to the company SALT LAKE CITY , Jan. 22, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company.
USANA Appoints New Chief Scientific Officer
Neutral
Business Wire
1 month ago
USANA Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and fiscal year 2024 results will be released after the close of market on Tuesday, February 25, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with.
USANA Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
Positive
Zacks Investment Research
1 month ago
Is USANA Health Sciences (USNA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is USANA Health Sciences (USNA) Stock Undervalued Right Now?
Charts implemented using Lightweight Charts™